10 20 30 40 50 60 70 80 4RN6 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE/HYDROLASE INHIBITOR 23-OCT-14 4RN6
TITLE STRUCTURE OF PRETHROMBIN-2 MUTANT S195A BOUND TO THE ACTIVE SITE TITLE 2 INHIBITOR ARGATROBAN
COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN HEAVY CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 333-622; COMPND 5 EC: 3.4.21.5; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS SERINE PROTEASE, PRETHROMBIN-2, AUTOACTIVATION, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR N.POZZI,Z.CHEN,F.ZAPATA,W.NIU,S.BARRANCO-MEDINA,L.A.PELC,E.DI CERA
REVDAT 1 05-NOV-14 4RN6 0
SPRSDE 05-NOV-14 4RN6 4HFY
JRNL AUTH N.POZZI,Z.CHEN,F.ZAPATA,W.NIU,S.BARRANCO-MEDINA,L.A.PELC, JRNL AUTH 2 E.DI CERA JRNL TITL AUTOACTIVATION OF THROMBIN PRECURSORS. JRNL REF J.BIOL.CHEM. V. 288 11601 2013 JRNL REFN ISSN 0021-9258 JRNL PMID 23467412 JRNL DOI 10.1074/JBC.M113.451542
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.POZZI,Z.CHEN,F.ZAPATA,L.A.PELC,S.BARRANCO-MEDINA,E.DI CERA REMARK 1 TITL CRYSTAL STRUCTURES OF PRETHROMBIN-2 REVEAL ALTERNATIVE REMARK 1 TITL 2 CONFORMATIONS UNDER IDENTICAL SOLUTION CONDITIONS AND THE REMARK 1 TITL 3 MECHANISM OF ZYMOGEN ACTIVATION. REMARK 1 REF BIOCHEMISTRY V. 50 10195 2011 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 22049947 REMARK 1 DOI 10.1021/BI2015019
REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : -1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 9833 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.252 REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.343 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 477 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.51 REMARK 3 BIN R VALUE (WORKING SET) : 0.3010 REMARK 3 BIN FREE R VALUE SET COUNT : 27 REMARK 3 BIN FREE R VALUE : 0.4520 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4610 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.07000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; 0.007 ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; 1.105 ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; 5.790 ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ;37.181 ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ;20.336 ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ;17.547 ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; 0.078 ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; 0.004 ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; 0.273 ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; 0.508 ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; 0.499 ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; 0.876 ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS
REMARK 4 REMARK 4 4RN6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-14. REMARK 100 THE RCSB ID CODE IS RCSB087553.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10552 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 32.130 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.15600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.44700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP FROM CCP4 REMARK 200 STARTING MODEL: 3SQH REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 8.5, 200 MM LI2SO4 AND REMARK 280 30% PEG 3000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.92000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 149B REMARK 465 VAL A 149C REMARK 465 GLY A 149D REMARK 465 LYS A 149E REMARK 465 GLY A 150 REMARK 465 GLN A 151 REMARK 465 ASN B 149B REMARK 465 VAL B 149C REMARK 465 GLY B 149D REMARK 465 LYS B 149E REMARK 465 GLY B 150 REMARK 465 GLN B 151
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 111 C - N - CA ANGL. DEV. = 9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 -83.77 -131.42 REMARK 500 SER A 11 -22.49 70.15 REMARK 500 SER A 14I 24.90 48.62 REMARK 500 GLU A 18 -52.22 -139.08 REMARK 500 LEU A 41 -72.78 -103.14 REMARK 500 ALA A 44 -155.57 -162.43 REMARK 500 ASP A 49 37.70 -77.43 REMARK 500 ARG A 50 -33.73 -163.79 REMARK 500 TYR A 60A 84.86 -156.23 REMARK 500 ASP A 60E 57.79 37.70 REMARK 500 ARG A 75 116.11 -169.76 REMARK 500 ASN A 78 -0.94 62.88 REMARK 500 GLU A 97A -71.78 -136.17 REMARK 500 ASP A 102 77.33 -64.07 REMARK 500 LYS A 109 -85.08 -69.23 REMARK 500 SER A 115 -151.10 -111.98 REMARK 500 SER A 153 -92.41 -50.94 REMARK 500 LEU A 155 126.52 -33.88 REMARK 500 ASN A 179 13.57 -69.64 REMARK 500 ARG A 187 52.45 -97.49 REMARK 500 ASN A 204B 22.97 -148.85 REMARK 500 ASN A 205 -10.85 63.77 REMARK 500 VAL A 213 104.52 -58.10 REMARK 500 SER A 214 -77.96 -92.24 REMARK 500 CYS A 220 -115.78 -154.87 REMARK 500 ASP A 221 99.14 -66.16 REMARK 500 PHE A 245 -57.38 -129.67 REMARK 500 PHE B 7 -78.92 -114.89 REMARK 500 SER B 11 82.76 45.84 REMARK 500 LYS B 14A 3.38 -59.94 REMARK 500 THR B 14B 7.36 -153.08 REMARK 500 SER B 14I 19.60 52.20 REMARK 500 VAL B 17 98.35 -67.53 REMARK 500 LEU B 40 95.12 -65.49 REMARK 500 CYS B 42 -152.96 -146.31 REMARK 500 LEU B 59 -75.10 -93.65 REMARK 500 TYR B 60A 86.50 -158.90 REMARK 500 ASN B 60G 103.54 -172.87 REMARK 500 ASN B 62 27.81 -79.49 REMARK 500 TYR B 76 122.66 -28.09 REMARK 500 ASN B 78 -3.66 60.56 REMARK 500 GLU B 86 -75.19 -72.40 REMARK 500 ARG B 93 44.83 -105.89 REMARK 500 GLU B 97A -54.06 -148.04 REMARK 500 PRO B 111 146.14 -33.36 REMARK 500 SER B 115 -157.47 -114.34 REMARK 500 ASP B 186A -74.97 -48.20 REMARK 500 GLU B 186B 82.01 -69.45 REMARK 500 ARG B 187 45.38 -109.87 REMARK 500 VAL B 213 98.47 -55.65 REMARK 500 REMARK 500 THIS ENTRY HAS 53 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL
REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: (2R,4R)-4-METHYL-1-(N~2~-{[(3S)-3-METHYL-1,2,3,4- REMARK 630 TETRAHYDROQUINOLIN-8-YL]SULFONYL}-L-ARGINYL)PIPERIDINE-2- REMARK 630 CARBOXYLIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 15U A 301 REMARK 630 15U B 301 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 15Y ARG MCP REMARK 630 DETAILS: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15U A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15U B 301
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3SQH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PRE THROMBIN-2 MUTANT S195A IN THE REMARK 900 OPEN FORM
DBREF 4RN6 A 1C 247 UNP P00734 THRB_HUMAN 333 622 DBREF 4RN6 B 1C 247 UNP P00734 THRB_HUMAN 333 622
SEQADV 4RN6 ALA A 195 UNP P00734 SER 568 ENGINEERED MUTATION SEQADV 4RN6 ALA B 195 UNP P00734 SER 568 ENGINEERED MUTATION
SEQRES 1 A 290 GLU ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SEQRES 2 A 290 SER LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER SEQRES 3 A 290 TYR ILE ASP GLY ARG ILE VAL GLU GLY SER ASP ALA GLU SEQRES 4 A 290 ILE GLY MET SER PRO TRP GLN VAL MET LEU PHE ARG LYS SEQRES 5 A 290 SER PRO GLN GLU LEU LEU CYS GLY ALA SER LEU ILE SER SEQRES 6 A 290 ASP ARG TRP VAL LEU THR ALA ALA HIS CYS LEU LEU TYR SEQRES 7 A 290 PRO PRO TRP ASP LYS ASN PHE THR GLU ASN ASP LEU LEU SEQRES 8 A 290 VAL ARG ILE GLY LYS HIS SER ARG THR ARG TYR GLU ARG SEQRES 9 A 290 ASN ILE GLU LYS ILE SER MET LEU GLU LYS ILE TYR ILE SEQRES 10 A 290 HIS PRO ARG TYR ASN TRP ARG GLU ASN LEU ASP ARG ASP SEQRES 11 A 290 ILE ALA LEU MET LYS LEU LYS LYS PRO VAL ALA PHE SER SEQRES 12 A 290 ASP TYR ILE HIS PRO VAL CYS LEU PRO ASP ARG GLU THR SEQRES 13 A 290 ALA ALA SER LEU LEU GLN ALA GLY TYR LYS GLY ARG VAL SEQRES 14 A 290 THR GLY TRP GLY ASN LEU LYS GLU THR TRP THR ALA ASN SEQRES 15 A 290 VAL GLY LYS GLY GLN PRO SER VAL LEU GLN VAL VAL ASN SEQRES 16 A 290 LEU PRO ILE VAL GLU ARG PRO VAL CYS LYS ASP SER THR SEQRES 17 A 290 ARG ILE ARG ILE THR ASP ASN MET PHE CYS ALA GLY TYR SEQRES 18 A 290 LYS PRO ASP GLU GLY LYS ARG GLY ASP ALA CYS GLU GLY SEQRES 19 A 290 ASP ALA GLY GLY PRO PHE VAL MET LYS SER PRO PHE ASN SEQRES 20 A 290 ASN ARG TRP TYR GLN MET GLY ILE VAL SER TRP GLY GLU SEQRES 21 A 290 GLY CYS ASP ARG ASP GLY LYS TYR GLY PHE TYR THR HIS SEQRES 22 A 290 VAL PHE ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE ASP SEQRES 23 A 290 GLN PHE GLY GLU SEQRES 1 B 290 GLU ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SEQRES 2 B 290 SER LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER SEQRES 3 B 290 TYR ILE ASP GLY ARG ILE VAL GLU GLY SER ASP ALA GLU SEQRES 4 B 290 ILE GLY MET SER PRO TRP GLN VAL MET LEU PHE ARG LYS SEQRES 5 B 290 SER PRO GLN GLU LEU LEU CYS GLY ALA SER LEU ILE SER SEQRES 6 B 290 ASP ARG TRP VAL LEU THR ALA ALA HIS CYS LEU LEU TYR SEQRES 7 B 290 PRO PRO TRP ASP LYS ASN PHE THR GLU ASN ASP LEU LEU SEQRES 8 B 290 VAL ARG ILE GLY LYS HIS SER ARG THR ARG TYR GLU ARG SEQRES 9 B 290 ASN ILE GLU LYS ILE SER MET LEU GLU LYS ILE TYR ILE SEQRES 10 B 290 HIS PRO ARG TYR ASN TRP ARG GLU ASN LEU ASP ARG ASP SEQRES 11 B 290 ILE ALA LEU MET LYS LEU LYS LYS PRO VAL ALA PHE SER SEQRES 12 B 290 ASP TYR ILE HIS PRO VAL CYS LEU PRO ASP ARG GLU THR SEQRES 13 B 290 ALA ALA SER LEU LEU GLN ALA GLY TYR LYS GLY ARG VAL SEQRES 14 B 290 THR GLY TRP GLY ASN LEU LYS GLU THR TRP THR ALA ASN SEQRES 15 B 290 VAL GLY LYS GLY GLN PRO SER VAL LEU GLN VAL VAL ASN SEQRES 16 B 290 LEU PRO ILE VAL GLU ARG PRO VAL CYS LYS ASP SER THR SEQRES 17 B 290 ARG ILE ARG ILE THR ASP ASN MET PHE CYS ALA GLY TYR SEQRES 18 B 290 LYS PRO ASP GLU GLY LYS ARG GLY ASP ALA CYS GLU GLY SEQRES 19 B 290 ASP ALA GLY GLY PRO PHE VAL MET LYS SER PRO PHE ASN SEQRES 20 B 290 ASN ARG TRP TYR GLN MET GLY ILE VAL SER TRP GLY GLU SEQRES 21 B 290 GLY CYS ASP ARG ASP GLY LYS TYR GLY PHE TYR THR HIS SEQRES 22 B 290 VAL PHE ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE ASP SEQRES 23 B 290 GLN PHE GLY GLU
HET 15U A 301 35 HET 15U B 301 35
HETNAM 15U (2R,4R)-4-METHYL-1-(N~2~-{[(3S)-3-METHYL-1,2,3,4- HETNAM 2 15U TETRAHYDROQUINOLIN-8-YL]SULFONYL}-L-ARGINYL) HETNAM 3 15U PIPERIDINE-2-CARBOXYLIC ACID
HETSYN 15U S-ARGATROBAN
FORMUL 3 15U 2(C23 H36 N6 O5 S)
HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 2 GLU A 14C GLU A 14H 1 6 HELIX 3 3 ALA A 55 CYS A 58 5 4 HELIX 4 4 PRO A 60B ASP A 60E 5 4 HELIX 5 5 THR A 60I ASN A 62 5 3 HELIX 6 6 ASP A 125 LEU A 130 1 9 HELIX 7 7 GLY A 142 TRP A 148 1 7 HELIX 8 8 GLU A 164 THR A 172 1 9 HELIX 9 9 ASP A 189 GLY A 193 5 5 HELIX 10 10 VAL A 231 ARG A 233 5 3 HELIX 11 11 LEU A 234 PHE A 245 1 12 HELIX 12 12 THR B 14B GLU B 14H 1 7 HELIX 13 13 ALA B 55 LEU B 59 5 5 HELIX 14 14 TYR B 60A ASP B 60E 5 5 HELIX 15 15 THR B 60I ASN B 62 5 3 HELIX 16 16 ASP B 125 LEU B 130 1 9 HELIX 17 17 GLY B 142 TRP B 148 1 7 HELIX 18 18 GLU B 164 SER B 171 1 8 HELIX 19 19 ASP B 189 GLY B 193 5 5 HELIX 20 20 LEU B 234 PHE B 245 1 12
SHEET 1 A 5 SER A 20 ASP A 21 0 SHEET 2 A 5 GLN A 156 PRO A 161 -1 O VAL A 157 N SER A 20 SHEET 3 A 5 LYS A 135 GLY A 140 -1 N GLY A 140 O GLN A 156 SHEET 4 A 5 PHE A 199 LYS A 202 -1 O VAL A 200 N ARG A 137 SHEET 5 A 5 TRP A 207 GLN A 209 -1 O TYR A 208 N MET A 201 SHEET 1 B 7 LYS A 81 SER A 83 0 SHEET 2 B 7 LEU A 64 ILE A 68 -1 N ILE A 68 O LYS A 81 SHEET 3 B 7 GLN A 30 ARG A 35 -1 N PHE A 34 O LEU A 65 SHEET 4 B 7 GLU A 39 LEU A 46 -1 O GLU A 39 N ARG A 35 SHEET 5 B 7 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 45 SHEET 6 B 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 7 B 7 LEU A 85 ILE A 90 -1 N TYR A 89 O LEU A 105 SHEET 1 C 2 LEU A 60 TYR A 60A 0 SHEET 2 C 2 LYS A 60F ASN A 60G-1 O LYS A 60F N TYR A 60A SHEET 1 D 3 MET A 180 ALA A 183 0 SHEET 2 D 3 GLY A 226 THR A 229 -1 O TYR A 228 N PHE A 181 SHEET 3 D 3 VAL A 213 TRP A 215 -1 N TRP A 215 O PHE A 227 SHEET 1 E 7 GLY B 19 ASP B 21 0 SHEET 2 E 7 GLN B 156 PRO B 161 -1 O VAL B 157 N SER B 20 SHEET 3 E 7 LYS B 135 GLY B 140 -1 N GLY B 140 O GLN B 156 SHEET 4 E 7 PRO B 198 LYS B 202 -1 O VAL B 200 N ARG B 137 SHEET 5 E 7 TRP B 207 TRP B 215 -1 O TYR B 208 N MET B 201 SHEET 6 E 7 GLY B 226 THR B 229 -1 O PHE B 227 N TRP B 215 SHEET 7 E 7 MET B 180 ALA B 183 -1 N PHE B 181 O TYR B 228 SHEET 1 F 7 LYS B 81 SER B 83 0 SHEET 2 F 7 LEU B 64 ILE B 68 -1 N ILE B 68 O LYS B 81 SHEET 3 F 7 GLN B 30 ARG B 35 -1 N PHE B 34 O LEU B 65 SHEET 4 F 7 GLU B 39 LEU B 46 -1 O ALA B 44 N VAL B 31 SHEET 5 F 7 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45 SHEET 6 F 7 ALA B 104 LEU B 108 -1 O MET B 106 N VAL B 52 SHEET 7 F 7 LEU B 85 ILE B 90 -1 N GLU B 86 O LYS B 107
SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.03 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.04 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.05 SSBOND 5 CYS B 1 CYS B 122 1555 1555 2.03 SSBOND 6 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 7 CYS B 168 CYS B 182 1555 1555 2.04 SSBOND 8 CYS B 191 CYS B 220 1555 1555 2.04
CISPEP 1 SER A 36A PRO A 37 0 -0.65 CISPEP 2 SER B 36A PRO B 37 0 -6.82
SITE 1 AC1 8 HIS A 57 TYR A 60A TRP A 60D LEU A 144 SITE 2 AC1 8 TRP A 148 TRP A 215 GLY A 216 GLY A 219 SITE 1 AC2 10 HIS B 57 TYR B 60A TRP B 148 VAL B 213 SITE 2 AC2 10 SER B 214 TRP B 215 GLY B 216 GLU B 217 SITE 3 AC2 10 GLY B 219 GLY B 226
CRYST1 43.919 81.840 77.761 90.00 100.62 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022769 0.000000 0.004269 0.00000
SCALE2 0.000000 0.012219 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013084 0.00000